Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort

ConclusionsThe cumulative incidence of composite VTE during cancer treatment was higher in pancreatic cancer than in other cancer types. Some risk factors for VTE prevalence at cancer diagnosis were identified. Although VTE prevalence at cancer diagnosis did not predict the subsequent 1-year incidence of composite VTE, it was a significant predictor of other events such as all-cause death in pancreatic cancer patients.Trial registrationUMIN Clinical Trials Registry; UMIN000024942
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research